Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Hi Guys, when do you think the next bit of meaningful news will be? And what do u think it will be about? To be honest this share matters to me a lot, and it would be nice to have some good news during lockdown. I know we don't have a crystal ball, but I'm wondering how trials & Bluehat are progressing. Sock.
...By the way, my last post was not meant to be a dig at the Company. They will be doing their utmost to make a success of what is a fantastic product in a huge Chinese market.
Hopefully there will be a trading update before the results but we don't always get one.
Hi Gixer. Thank you. And thanks for all the research you do! Do you know roughly when the trading update is likely to be? Sock :)
Last year it was to be the end of June but delayed it till the end of July
https://otp.investis.com/clients/uk/provexis_plc/rns/regulatory-story.aspx?cid=1569&newsid=1303330
Unless they have news of Blue hat I find it difficult to believe they will give a trading update , otherwise what are they going to say , “all progressing well again “ !
And it was delayed last year because they were waiting for the news of tie up with By health
''Doing their utmost '' , yes refiling those Patents ever year must be a real chore for IF , or does his secretary do it now ? Socks I can not see that PXS are doing anything much at all TBH.
Suppose that would be the main reason to get a trading update.
The fact that we cannot see PXS doing "anything much" doesn't mean they have been doing nothing.
Personally I would like to see a bit more detail on what By-Health is achieving wrt Fruitflow even if Blue Cap isn't imminent.
"X" amount of studies and Blue Cap is required isnt enough IMO.
What are the studies (the ones we havent found) for and what health claim(s) are B-H after would be good for starters.
Did a search for Fruitflow and this came up . AINST AIR POLLUTION RELATED DISEASES
US - 30.04.2020
Int.Class
A61K 31/585
Appl.No 16605627
Applicant DSM IP Assets B.V.
Inventor Igor BENDIK
The present invention relates to systemic detoxification by using extracts of Withania somnifera (ashwagandha) and its Nrf2-activating components withaferin-A, 12-deoxywithastramonolide, and Quresimine A. When ingested, the transcription factor Nrf2, which is a crucial element in intracellular detoxification pathways, leads to elimination of potentially toxic compounds. In parallel, the expression of inflammatory cytokines is decreased. Therefore, the extract can be used to reduce the adverse effects of air pollution generally (and especially of particulate air pollution), which includes: cardiovascular problems, respiratory diseases, and chronic inflammation of tissues that come into contact with air borne particles.
Https://patentscope.wipo.int/search/en/detail.jsf?docId=US293957659&_cid=P10-KBRAPQ-95618-1.
Withania somnifera, commonly called ashwagandha, is a winter cherry tropical to the Solanaceae family that is used in treating a wide variety of illnesses including asthma, diabetes, hypertension, stress, arthritic diseases, and cancer.
Sent from my iPad
HTTPS://patentscope.wipo.int/search/en/detail.jsf?docId=US293957659&_cid=P10-KBRAPQ-95618-1
At least it states it can include Fruitflow as one of the active ingredients
sphinx
thx for posting. I saw this a few months back and wondered why they bothered mentioning FF specifically in the patent. I hoped it was because FF wouldn’t be a standalone product but part of a ****tail of active ingredients in many different products, each one aimed at a specific market - FF plus in all but name.
I believe this is what we are seeing with the latest products.
It is interesting to see Seven Seas are adopting a similar approach - Seven Seas plus tumeric for example.
I agree with you gixer, IF should start putting more meat in the updates if he is to continue to receive shareholder support
W$
We've always been aware of the limitations which apply to Provexis giving news of other brands' final products. In jittery financial world economies, I wonder if we'll see continued confidence in new offerings. Fruitflow is certainly highly valid for the established health benefits, we can but hope that it is something that will break through in light of the reported adverse effects of covid. I can only guess why we can't outright shout it from the rooftops. Frustrating
Going back to my earlier post about getting more info from pxs about by-health.
Here is an extract from by-healths 2019 annual report.
"8. Construct a multi-business R&D system and consolidate the innovation strength
In 2020, in accordance with the company’s strategy and product layout, the company will build multiple
completely independent R&D systems including Vitamin & Dietary Supplements and OTC, continue to drive
up the construction of “overseas R&D centers”, deepen nutrition and anti-aging research and related product
transformation, promote research on platelet function-related nutritional interventions and the application of
related new functions and conduct cutting-edge research on “homeostasis” health assessment and personalized
nutritional interventions with Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences."
http://www.by-health.com/en/Download/Attachment?id=300618
Now although it doesn't mention FF by name, you can only guess that ("promote research on platelet function-related nutritional interventions and the application of related new functions ") they (by-health) are happy to promote FF related research.
IT Does sound like they are committed to selling ff products nationally , which will be great news for us , it’s just when !